PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
28-Jul-2021 Medacta Expands Hip Revision Portfolio, Unveiling Cutting-Edge Implants for Acetabulum and Femur Medacta Group SA
28-Jul-2021 atai Life Sciences launches InnarisBio to advance delivery of therapeutics for mental health disorders with a licence to develop novel sol-gel intranasal drug delivery platform technology from UniQuest atai Life Sciences
28-Jul-2021 MetrioPharm Selected by European Commission for Funding as Part of the "HERA Incubator” MetrioPharm
28-Jul-2021 Flow chemistry specialists reach 700 publications landmark Vapourtec
28-Jul-2021 MetrioPharm Selected by European Commission for Funding as Part of the "HERA Incubator” B3C newswire
28-Jul-2021 Thermo Fisher Scientific Commits to Achieve Net-Zero Carbon Emissions by 2050 Thermo Fisher Scientific
28-Jul-2021 AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and Age-Related Diseases AbbVie and Calico
28-Jul-2021 Sanofi provides update on avalglucosidase alfa EU submission for patients with Pompe Disease Sanofi
28-Jul-2021 Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent Milestone Payments Amgen
28-Jul-2021 CARMAT announces the first human implant of its Aeson® artificial heart in Germany CARMAT
28-Jul-2021 Vitruvia Medical AG: Successful certification for the reprocessing of 'critical C' devices - Vitruvia Medical now also providing circular systems for highest risk-level medical devices Vitruvia Medical AG
28-Jul-2021 Byondis and Glycotope Enter Platform Access Agreement for Discovery and Development of Antibodies Against Novel GlycoTargets Byondis B.V
28-Jul-2021 Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017 Bone Therapeutics
28-Jul-2021 Asceneuron CEO Dirk Beher to Speak at Alzheimer’s Association International Conference Asceneuron SA
28-Jul-2021 BRAIN Biotech AG: Sartorius and BRAIN jointly researching and adapting novel CRISPR Cas-nucleases BRAIN Biotech AG
28-Jul-2021 APONTIS PHARMA reports accelerated growth in first half of 2021 - Single Pill revenues +83% to EUR 14.0 million APONTIS PHARMA AG
28-Jul-2021 Relief Reports that its U.S. Collaboration Partner has Announced Emergency Use Authorization of Aviptadil in Nation of Georgia RELIEF THERAPEUTICS Holdings AG
28-Jul-2021 Relief and AdVita Close Definitive Agreement for Relief to Acquire All Outstanding Shares of AdVita RELIEF THERAPEUTICS Holdings AG
27-Jul-2021 Xihua Scientific Selects LifeSphere MultiVigilance to Advance Pharmacovigilance Services ArisGlobal
27-Jul-2021 ​​​​​​​Half Year Results Stronger than Expected; Eckert & Ziegler Increases Profit Forecast by approximately 20% Eckert & Ziegler Strahlen- und Medizintechnik AG